GB0212701D0 - Immunoliposomes - Google Patents
ImmunoliposomesInfo
- Publication number
- GB0212701D0 GB0212701D0 GBGB0212701.7A GB0212701A GB0212701D0 GB 0212701 D0 GB0212701 D0 GB 0212701D0 GB 0212701 A GB0212701 A GB 0212701A GB 0212701 D0 GB0212701 D0 GB 0212701D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- immunoliposomes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0212701.7A GB0212701D0 (en) | 2002-05-31 | 2002-05-31 | Immunoliposomes |
| PCT/GB2003/002359 WO2003101427A1 (en) | 2002-05-31 | 2003-05-30 | Immunoliposomes formed with aggregated antibody |
| AU2003241028A AU2003241028A1 (en) | 2002-05-31 | 2003-05-30 | Immunoliposomes formed with aggregated antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0212701.7A GB0212701D0 (en) | 2002-05-31 | 2002-05-31 | Immunoliposomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0212701D0 true GB0212701D0 (en) | 2002-07-10 |
Family
ID=9937863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0212701.7A Ceased GB0212701D0 (en) | 2002-05-31 | 2002-05-31 | Immunoliposomes |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003241028A1 (en) |
| GB (1) | GB0212701D0 (en) |
| WO (1) | WO2003101427A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101644144B1 (en) | 2008-07-11 | 2016-07-29 | 유니버셜 바이오센서스 피티와이 엘티디. | Enhanced immunoassay sensor |
| US20160298187A1 (en) * | 2015-04-08 | 2016-10-13 | Verily Life Sciences Llc | Methods of tagging particles for multiplexed functional screening |
| IT201900007222A1 (en) | 2019-05-24 | 2020-11-24 | Univ Degli Studi Di Torino | COMPOSITION OF LIPOSOMES AND METHOD OF DOSAGE BASED ON THE USE OF THE SAME |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69720A (en) * | 1983-09-14 | 1987-08-31 | Univ Ramot | Anti-tumor pharmaceutical compositions comprising liposome-bound porphyrins |
| US5059421A (en) * | 1985-07-26 | 1991-10-22 | The Liposome Company, Inc. | Preparation of targeted liposome systems of a defined size distribution |
| CA2188812A1 (en) * | 1994-05-26 | 1995-12-07 | Mark De Boer | New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
-
2002
- 2002-05-31 GB GBGB0212701.7A patent/GB0212701D0/en not_active Ceased
-
2003
- 2003-05-30 WO PCT/GB2003/002359 patent/WO2003101427A1/en not_active Application Discontinuation
- 2003-05-30 AU AU2003241028A patent/AU2003241028A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003241028A1 (en) | 2003-12-19 |
| WO2003101427A1 (en) | 2003-12-11 |
| WO2003101427A8 (en) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50311874D1 (en) | Spirocyclische cyclohexan-derivate | |
| DE50312422D1 (en) | Aryloxime | |
| AU2003249738A8 (en) | Ostoscope | |
| AU2003297193A8 (en) | Meta-web | |
| DE50309217D1 (en) | Benzimidazolderivate | |
| AU2003252028A8 (en) | Heterodiamondoids | |
| AU2003279495A8 (en) | Alert-modeling | |
| DE50303619D1 (en) | Reibschweissvorrichtung | |
| DE50308027D1 (en) | Cyclohexyl-harnstoff-derivate | |
| DE50307787D1 (en) | Isophthalsäurederivate | |
| DE50311133D1 (en) | Carbonsäureamide | |
| DE50312412D1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative | |
| AU2003264900A8 (en) | Cast-cutter | |
| AU2002367810A8 (en) | Bis-transition-metal-chelate-probes | |
| DE50310169D1 (en) | Lingual-retainer | |
| DE50304964D1 (en) | Handhobelmaschine | |
| AU2003262681A8 (en) | Hemo-aide | |
| GB0212701D0 (en) | Immunoliposomes | |
| DE10392833D2 (en) | Geotextilie | |
| AU2002341221A8 (en) | Honey-brandy | |
| AU2003253735A8 (en) | Vacuolins | |
| DE50309021D1 (en) | Etherlacton | |
| AU154296S (en) | Section | |
| GB0212493D0 (en) | Mon-board | |
| AU2327P (en) | Archnah Arctotis fastuosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |